Owlet (NYSE:OWLT – Get Free Report) is one of 511 publicly-traded companies in the “Healthcare Equipment & Supplies” industry, but how does it weigh in compared to its competitors? We will compare Owlet to similar companies based on the strength of its earnings, analyst recommendations, profitability, institutional ownership, valuation, dividends and risk.
Profitability
This table compares Owlet and its competitors’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Owlet | -8.61% | -601.24% | -15.96% |
| Owlet Competitors | -276.78% | -149.08% | -21.73% |
Earnings and Valuation
This table compares Owlet and its competitors top-line revenue, earnings per share and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Owlet | $114.41 million | -$39.68 million | -5.66 |
| Owlet Competitors | $1.90 billion | $138.25 million | 9.36 |
Owlet’s competitors have higher revenue and earnings than Owlet. Owlet is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Volatility and Risk
Owlet has a beta of 2.17, indicating that its share price is 117% more volatile than the S&P 500. Comparatively, Owlet’s competitors have a beta of 2.57, indicating that their average share price is 157% more volatile than the S&P 500.
Analyst Recommendations
This is a summary of current recommendations for Owlet and its competitors, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Owlet | 1 | 1 | 3 | 0 | 2.40 |
| Owlet Competitors | 4270 | 10527 | 18284 | 825 | 2.46 |
Owlet presently has a consensus target price of $15.00, suggesting a potential upside of 253.52%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 19.45%. Given Owlet’s higher possible upside, research analysts clearly believe Owlet is more favorable than its competitors.
Insider and Institutional Ownership
72.6% of Owlet shares are held by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are held by institutional investors. 36.2% of Owlet shares are held by company insiders. Comparatively, 14.8% of shares of all “Healthcare Equipment & Supplies” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Summary
Owlet competitors beat Owlet on 7 of the 13 factors compared.
About Owlet
Owlet, Inc. provides digital parenting solutions in the United States and internationally. The company's platform focuses on giving real-time data and insights to parents. It offers Dream Sock, a wearable infant health monitor equipped with pulse oximetry technology to track vitals signs, such as pulse rate, oxygen, activity, and sleep patterns; BabySat which is intended for infants with heightened health risk; Owlet Cam, a monitoring device in smartphones that offers video and audio, predictive sleep insights, and cry detections; and accessories, including Owlet Sleeper, as well as Duo and Dream Duo that combines Smart Sock with the Owlet Cam. The company was founded in 2012 and is headquartered in Lehi, Utah.
Receive News & Ratings for Owlet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owlet and related companies with MarketBeat.com's FREE daily email newsletter.
